HomeNewsBusinessHCL Tech’s acquisitions to continue as it looks to expand tech offering and newer geographies: CEO C Vijayakumar

HCL Tech’s acquisitions to continue as it looks to expand tech offering and newer geographies: CEO C Vijayakumar

“Acquisitions in three areas to enhance and broad-base our digital capabilities, innovative IP to drive for more growth for our products and platform segment and expand and bring market presence in newer geographies,” said C Vijayakumar - the president and chief executive officer of HCL Technologies.

October 17, 2020 / 10:08 IST
Story continues below Advertisement

Noida-based IT services major HCL Tech is confident about its products and platform strategy paying off in the coming quarters despite analysts' opinion about sustainability of the product business.

The company is also looking to expand its presence in Europe and Asia Pacific and product and platform offerings and is more open to acquisitions.

Story continues below Advertisement

In a conversation with Moneycontrol, C Vijayakumar - the president and chief executive officer of HCL Technologies - shares more about what drives the company’s confidence in this space. Though there are no plans to run products and platforms as separate businesses, Vijayakumar does not completely rule out the option as well.

Q: HCL Tech saw a 20 percent quarter-on-quarter increase in deal wins in Q2, a record high you had pointed out during the earnings call. Could you give us the nature of these deals and what was a key driver?

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show